Expanesthetics Inc. is at the forefront of developing innovative inhaled general anesthetics, marking a significant advancement in the field since the early 1990s. Their lead drug candidate represents the first new inhaled anesthetic to enter the development stage in decades, highlighting the company's commitment to transforming anesthesia practices. In addition to enhancing clinical efficacy, Expanesthetics is focused on creating environmentally sustainable anesthetic solutions. Their approach involves designing anesthetics that can be disposed of with surgical waste rather than being released into the atmosphere, thereby reducing the environmental impact associated with traditional anesthetic gases.

The company is also exploring the application of their innovative technologies to conventional anesthetics, aiming to improve both patient outcomes and ecological sustainability. By collaborating with over 100 anesthesia clinicians, Expanesthetics is building a community of pioneers dedicated to advancing anesthesia practices. This collaborative effort underscores the company's mission to not only innovate within the medical field but also to address pressing environmental concerns associated with anesthetic use.

United States

Expanesthetics is working to create inhaled general anesthetics with fewer side effects than currently available agents.

Expanesthetics Inc.

Company Details